ROCK-D

K
Kenneth Lim

Primary Investigator

Enrolling By Invitation
18-100 years
All
Phase N/A
140 participants needed
1 Location

Brief description of study

The purpose of the study is to identify the best diagnostic test that could be used to assess cardiovascular risk in patients on dialysis. The study will also develop a new scoring system that can more accurately calculate the risk of developing an adverse cardiovascular event.

Detailed description of study

The central hypothesis is that assessment of VO2Peak by CPET will be superior to other diagnostic tests for predicting future CV events in patients with advanced CKD on dialysis. We will test this hypothesis by completing the following aims:
 
AIM 1 (A) will determine the predictive value of VO2Peak compared to other clinically used tests (cardiac CT, T1 MRI, physical function testing) for predicting CV outcomes at 3-years; and (B) determine if changes in VO2Peak at 1-year are superior to baseline VO2Peak in predicting CV outcomes at 3-years.
 
AIM 2 will develop a new risk stratification model and assess whether the inclusion of functional indices can accurately prognosticate future CV outcomes in CKD compared to traditional risk scores.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: kidney failure, dialysis
  • Age: Between 18 Years - 100 Years
  • Gender: All

Inclusion Criteria:
  • ·         All patients aged 18 years or older.
    ·         All races and ethnicities. Both genders.
    ·         CKD stage 5D patients on thrice weekly hemodialysis for at least 3 months.
    ·         English speaking patients. 
Exclusion Criteria:
  • ·         Patients with malignancy requiring chemotherapy or metastatic disease.
    ·         Patients unable to exercise due to musculoskeletal issues.
    ·         Patients likely to not be available to complete all protocol-required study visits or procedures, and/or to comply with all required study procedures to the best of the patient, research team and Investigator’s knowledge.
    ·         Patients with active implanted medical devices (e.g. cardiac pacemaker, defibrillators).
    ·         Pregnancy or breastfeeding.
    ·         Contraindications to CPET testing as described in our CPET standard operating procedure (SOP)
    ·         Weight > 300 pounds.

Updated on 01 Aug 2024. Study ID: 15951; NEPH-IIR-ROCK-D
Please visit our main page to search for other studies you may be interested in. If you need help finding a study or have any questions, please contact us at inhealth@iu.edu

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center